- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Ventrus Biosciences Inc+ Add to Watchlist
VTUS:US2.6600 USD 0.1000 3.62%
As of 16:00:00 ET on 05/24/2013.
Company Profile for Ventrus Biosciences Inc (VTUS)
Ventrus Biosciences Inc. is a development stage pharmaceutical company. The Company is focused on late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. Ventrus's lead products are topical treatments for hemorroids, which targets a specific serotonin receptor.
Ventrus Biosciences Inc
Key Executives for Ventrus Biosciences Inc (VTUS)
|Russell H EllisonChairman/President/CEO||David J BarrettChief Financial Officer|